Cellebrite/$CLBT
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Cellebrite
Cellebrite DI Ltd provides AI-powered digital investigative and intelligence solutions that help public and private sector customers transform investigative workflows, make digital data more accessible and actionable, and improve the efficiency of mobile research and application security. Its solutions support law enforcement, defense, and intelligence agencies in advancing investigations, border security, counterterrorism, intelligence operations, and cyber operations. The company's software also enables enterprises and service providers to collect and review data for corporate investigations, eDiscovery, incident response, and mobile application validation. It operates in the Americas, APAC, and EMEA, with the majority of revenue from the Americas.
Ticker
$CLBT
Sector
Software & Cloud Services
Primary listing
Employees
1,285
Headquarters
Petah Tikva, Israel
Website
Cellebrite Metrics
BasicAdvanced
$3.6B
46.58
$0.31
1.33
-
Price and volume
Market cap
$3.6B
Beta
1.33
52-week high
$20.86
52-week low
$11.76
Average daily volume
2.1M
Financial strength
Current ratio
1.558
Quick ratio
1.466
Long term debt to equity
3.856
Total debt to equity
4.681
Profitability
EBITDA (TTM)
78.347
Gross margin (TTM)
84.20%
Net profit margin (TTM)
16.47%
Operating margin (TTM)
13.98%
Effective tax rate (TTM)
13.62%
Revenue per employee (TTM)
$370,000
Management effectiveness
Return on assets (TTM)
5.10%
Return on equity (TTM)
19.10%
Valuation
Price to earnings (TTM)
46.581
Price to revenue (TTM)
7.335
Price to book
7.31
Price to tangible book (TTM)
12.67
Price to free cash flow (TTM)
21.763
Free cash flow yield (TTM)
4.59%
Free cash flow per share (TTM)
0.663
Growth
Revenue change (TTM)
18.56%
Earnings per share change (TTM)
-122.95%
3-year revenue growth (CAGR)
20.68%
3-year earnings per share growth (CAGR)
-19.31%
What the Analysts think about Cellebrite
Analyst ratings (Buy, Hold, Sell) for Cellebrite stock.
Cellebrite Financial Performance
Revenues and expenses
Cellebrite Earnings Performance
Company profitability
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Cellebrite stock?
Cellebrite (CLBT) has a market cap of $3.6B as of March 15, 2026.
What is the P/E ratio for Cellebrite stock?
The price to earnings (P/E) ratio for Cellebrite (CLBT) stock is 46.58 as of March 15, 2026.
Does Cellebrite stock pay dividends?
No, Cellebrite (CLBT) stock does not pay dividends to its shareholders as of March 15, 2026.
When is the next Cellebrite dividend payment date?
Cellebrite (CLBT) stock does not pay dividends to its shareholders.
What is the beta indicator for Cellebrite?
Cellebrite (CLBT) has a beta rating of 1.33. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.